|
JAMA Network Open |
Comparison of SARS-CoV-2 Test Positivity in NCAA Division I Student Athletes vs Nonathletes at 12 Institutions |
1 |
Yes |
2/11/2025 |
|
JAMA Network Open |
Comparison of Seroconversion in Children and Adults With Mild COVID-19 |
1 |
Yes |
3/15/2025 |
|
JAMA Pediatrics |
Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting |
1 |
Yes |
6/21/2024 |
|
JAMA Psychiatry |
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care |
1 |
Yes |
11/3/2024 |
|
JAMA Network Open |
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada |
1 |
Yes |
8/8/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Complications of COVID-19 Nasopharyngeal Swab Test |
1 |
Yes |
5/10/2024 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Comprehensive Chemosensory Psychophysical Evaluation of Self-reported Gustatory Dysfunction in Patients With Long-term COVID-19 |
1 |
Yes |
1/14/2025 |
|
JAMA Surgery |
Comprehensive Review of Chest Tube Management - A Review |
1 |
Yes |
3/9/2025 |
|
JAMA |
Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents |
1 |
Yes |
8/30/2025 |
|
JAMA |
Confronting Health Care's Climate Crisis Conundrum - The Federal Government as Catalyst for Change |
1 |
Yes |
2/4/2025 |
|
JAMA |
Confronting the Delta Variant of SARS-CoV-2, Summer 2021 |
1 |
Yes |
8/26/2024 |
|
JAMA Oncology |
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) |
1 |
Yes |
4/21/2025 |
|
JAMA Internal Medicine |
Considering Cannabis Use in Differential Diagnosis - A Teachable Moment |
1 |
Yes |
1/4/2025 |
|
JAMA Psychiatry |
Contingency Management for Patients Receiving Medication for Opioid Use Disorder |
1 |
Yes |
10/6/2024 |
|
JAMA |
Contraception Selection, Effectiveness, and Adverse Effects - A Review |
1 |
Yes |
12/28/2024 |
|
American Medical Association |
Contracting in Private Practice |
0.25 |
Yes |
2/6/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Arkansas License Renewals |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Best Practices for Prescribing |
1.25 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Drug Diversion Prevention |
0.75 |
Yes |
2/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Controlled Substances Series: Fundamentals of Addiction and Addiction Treatment |
1.25 |
Yes |
2/9/2027 |
